Genzyme Corporation
3 drugs in NADAC|0 Generic,3 Brand
View Recalls (6)Genzyme Corporation lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $13.34 per unit. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$13.3447
$5.69 – $17.19
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
SEVELAMER CARBONATE market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Phosphate Binder therapeutic class
Review the broader class where Genzyme Corporation has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Genzyme Corporation make?
Genzyme Corporation lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Genzyme Corporation drugs?
The average NADAC across Genzyme Corporation's portfolio is $13.3447 per unit, ranging from $5.6852 to $17.1932.
What types of drugs does Genzyme Corporation make?
Genzyme Corporation makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Phosphate Binder (3).
Has Genzyme Corporation had any drug recalls?
6 FDA recalls are matched to Genzyme Corporation in the openFDA feed, most recently on Oct 12, 2017.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RENVELA 2.4 GM POWDER PACKET SEVELAMER CARBONATE | $17.1932 per EA | — |
RENVELA 0.8 GM POWDER PACKET SEVELAMER CARBONATE | $17.1558 per EA | — |
RENVELA 800 MG TABLET SEVELAMER CARBONATE | $5.6852 per EA | — |
FDA Recalls (6)
Recalls matched by company name. Verify current status with FDA.
Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.
Labeling: Incorrect or Missing Package Insert.
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01
Labeling: Incorrect or Missing Lot and/or Exp. Date
Hectorol (doxercalciferol injection) 2 mcg/1mL, Rx only, Manufactured by: Genzyme Biosurgery Corporation 500 Kendall Street, Cambridge, MA 02142, NDC 58468-0126-1
Labeling: Wrong barcode. An incorrect bar code was noted on the vial label of Hectorol 2 mcg/1mL vial.
Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Four vials per Carton, Carton contains 2 vials of Thyrogen and 2 vials of diluent, Storage: store at 2-8 C, Genzyme Corporation, Cambridge, MA 02142, NDC 58468-1849-04.
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Lumizyme (alglucosidase alpha), 50 mg/vial, For Intravenous Infusion Only, Rx Only, Manufactured by Genzyme Corportation, Cambridge, MA 02142, NDC 58468-0160-1
Labeling: Incorrect or Missing Lot and/or Exp Date